INTERNATIONAL PATENT: JANSSEN PHARMACEUTICA NV, JOHNSON & JOHNSON (CHINA) INVESTMENT LTD. FILES APPLICATION FOR "FORMULATIONS, CRYSTALLINE FORMS AND DOSAGE REGIMENS OF A MALT1 INHIBITOR"

GENEVA, Nov. 3 -- JANSSEN PHARMACEUTICA NV (Turnhoutseweg 30, 2340 Beerse), JOHNSON & JOHNSON (CHINA) INVESTMENT LTD. (2101, No. 1 Building, 65 Gui Qing RoadXuhui District, Shanghai 200233) filed a patent application (PCT/CN2025/091228) for "FORMULATIONS, CRYSTALLINE FORMS AND DOSAGE REGIMENS OF A MALT1 INHIBITOR" on Apr 25, 2025. With publication no. WO/2025/223551, the details related to the patent application was published on Oct 30, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): JI, Chongmin (Johnson & Johnson (China) Investment Ltd., 2101, No. 1 Building, 65 Gui Qing RoadXuhui District...